<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20210524051384N2</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2021-10-14</date_registration>
      <primary_sponsor>Rasht University of Medical Sciences</primary_sponsor>
      <public_title>The effect of using medical honey on the attachment of skin grafts</public_title>
      <acronym></acronym>
      <scientific_title>The study of using medical honey compared to stapler(Advan disposable skin stapler) for skin graft fixation in burn wounds</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2021-11-22</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>80</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/59104</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: In order to randomize the treatment between the groups, 4 permutation blocks
method will be used. Group A is the intervention group and group B is the control group,  and data randomization was performed with SAS software version 9.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Burns.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: Using honey instead of stapler to attach skin grafts.The medical honey used in this study is(Madi Hani) honey gel available in the market which is free from all the harms of ordinary honey to preserve all the properties of honey, including enzymes and diastases. Honey is refined at temperatures below 50 degrees. This honey has a low pH and high osmolarity with high antibacterial properties against the spectrum. A wide range of resistant strains along with maintaining the ideal moisture of the wound environment plays an effective role in healing. Patients with second and third deep grad of burn wounds require a graft, with burns less than 40% that are done in a single step that requires an autograft skin graft from the patient after the necessary and sufficient explanations about the study and the procedure for patients by an expert and physician and obtaining informed consent from 80 patients who are candidates for skin graft surgery using honey, which is removed from the patient with a skin dermatome device and placed in the appropriate area. Intervention 2: Control group: the use of stapler in attaching skin grafts. A stapler will be used to attach the skin graft to the underlying tissue. Using Advan disposable skin stapler which is disposable and is provided by Farab Surgeon Company, which is made and sterilized by the factory and is disposed of after use. Patients with second and third deep grad of burn wounds require a graft, with burns less than 40% that are done in a single step that requires an autograft skin graft from the patient after the necessary and sufficient explanations about the study and the procedure for patients by an expert and physician and obtaining informed consent from 80 patients who are candidates for skin graft surgery using honey, which is removed from the patient with a skin dermatome device and placed in the appropriate area.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for indecision in sharing IPD is I haven't decided yet - The release schedule is still unknown</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Dr.mohammadreza Mobayen</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Velayat Hospital, Namjo Street</address>
        <city>Rasht</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>4193713194</zip>
        <telephone>+98 13 3336 8540</telephone>
        <email>maziar.mobayen@gmail.com</email>
        <affiliation>Rasht University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Dr.Mohammadreza Mobayen</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Velayat Hospital, Namjo Street</address>
        <city>Rasht</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>4193713194</zip>
        <telephone>+98 13 3336 8540</telephone>
        <email>maziar.mobayen@gmail.com</email>
        <affiliation>Rasht University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>All patients with deep grade 2 and 3 of burn wounds who need a graft and burns with less than 40% which are performed in one- step.</inclusion_criteria>
      <agemin>20 years</agemin>
      <agemax>no limit</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Grafts that are performed late and in several stages and people with debilitating diseases and defected immune system, diabetes and Cortone users and burns injuries on the head, face, neck ,joints and allergies to honey and its products.</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>Z94.5</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Skin transplant status</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Drugs</i_code>
      <i_code>Treatment - Devices</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: Using honey instead of stapler to attach skin grafts.The medical honey used in this study is(Madi Hani) honey gel available in the market which is free from all the harms of ordinary honey to preserve all the properties of honey, including enzymes and diastases. Honey is refined at temperatures below 50 degrees. This honey has a low pH and high osmolarity with high antibacterial properties against the spectrum. A wide range of resistant strains along with maintaining the ideal moisture of the wound environment plays an effective role in healing. Patients with second and third deep grad of burn wounds require a graft, with burns less than 40% that are done in a single step that requires an autograft skin graft from the patient after the necessary and sufficient explanations about the study and the procedure for patients by an expert and physician and obtaining informed consent from 80 patients who are candidates for skin graft surgery using honey, which is removed from the patient with a skin dermatome device and placed in the appropriate area.</i_keyword>
      <i_keyword>Control group: the use of stapler in attaching skin grafts. A stapler will be used to attach the skin graft to the underlying tissue. Using Advan disposable skin stapler which is disposable and is provided by Farab Surgeon Company, which is made and sterilized by the factory and is disposed of after use. Patients with second and third deep grad of burn wounds require a graft, with burns less than 40% that are done in a single step that requires an autograft skin graft from the patient after the necessary and sufficient explanations about the study and the procedure for patients by an expert and physician and obtaining informed consent from 80 patients who are candidates for skin graft surgery using honey, which is removed from the patient with a skin dermatome device and placed in the appropriate area</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Efficiency of honey in attaching skin grafts. Timepoint: Duration of hospitalization. Method of measurement: By observing skin graft area and experienced burn specialist's opinion.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Evaluating the degree of displacement of grafted skin. Timepoint: On fifth, seventh and fourteenth days after surgery. Method of measurement: Based on millimeters.</sec_outcome>
      <sec_outcome>Infection after skin graft surgery. Timepoint: On seventh, fourteenth and one month after surgery. Method of measurement: Based on culture and Antibiogram.</sec_outcome>
      <sec_outcome>Hematoma. Timepoint: On fifth, seventh and fourteenth days after surgery. Method of measurement: By observing the accumulation of blood outside the vessels around the skin graft.</sec_outcome>
      <sec_outcome>The amount of pain. Timepoint: At 3, 6, 12 and 24 hours and by the third day after surgery. Method of measurement: Using the VAS criteria.</sec_outcome>
      <sec_outcome>Itching. Timepoint: At 3, 6, 12 and 24 hours and by the third day after surgery. Method of measurement: Through the 5-D criterion based on the lenght, severity, recovery and  disability degree caused by itching.</sec_outcome>
      <sec_outcome>Edema. Timepoint: On fifth, seventh and fourteenth days after surgery. Method of measurement: By observing the abnormal accumulation of interstitial fluid water under the skin graft and observing  by professionals.</sec_outcome>
      <sec_outcome>Shrinkage of the skin graft. Timepoint: On fifth, seventh and fourteenth days after surgery. Method of measurement: Based on millimeters (length and width).</sec_outcome>
      <sec_outcome>Follow-up of transplantation. Timepoint: On fifth, seventh and fourteenth days after surgery. Method of measurement: Based on discoloration of transplanted skin and photography and observing by burn specialist's opinion.</sec_outcome>
      <sec_outcome>Duration of hospitalization. Timepoint: Duration of patients' hospitalization. Method of measurement: Day.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Vice-Chancellor for Research, Guilan University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2021-09-29</approval_date>
        <contact_name>Research Ethic Committees of Guilan University of Medical science</contact_name>
        <contact_address>Guilan University of Medical science Rasht Guilan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
